Overdiagnosis: An unrecognised and growing worldwide problem in healthcare

1Brodersen J. How to conduct research on overdiagnosis: a keynote paper from the EGPRN May 2016, Tel Aviv. Eur J Gen Pract 2017; 23: 78-82.BrodersenJ.How to conduct research on overdiagnosis: a keynote paper from the EGPRN May 2016, Tel AvivEur J Gen Pract201723788210.1080/13814788.2017.1290795Search in Google Scholar

2Welch HG, Schwartz L, Woloshin S. Overdiagnosed: making people sick in the pursuit of health. Boston: Beacon Press, 2011.WelchHGSchwartzLWoloshinS.Overdiagnosed: making people sick in the pursuit of healthBostonBeacon Press2011Search in Google Scholar

3Carter SM, Rogers W, Heath I, Degeling C, Doust J, Barratt A. The challenge of overdiagnosis begins with its definition. BMJ 2015; 350: h869.CarterSMRogersWHeathIDegelingCDoustJBarrattA.The challenge of overdiagnosis begins with its definitionBMJ2015350h86910.1136/bmj.h869Search in Google Scholar

4Hansson A, Brodersen J, Reventlow S, Pettersson M. Opening Pandora’s box: the experiences of having an asymptomatic aortic aneurysm under surveillance. Health Risk Soc 2012; 14: 341-59.HanssonABrodersenJReventlowSPetterssonM.Opening Pandora’s box: the experiences of having an asymptomatic aortic aneurysm under surveillanceHealth Risk Soc2012143415910.1080/13698575.2012.680953Search in Google Scholar

5Brodersen J, Thorsen H, Kreiner S. Consequences of screening in lung cancer: development and dimensionality of a questionnaire. Value Health 2010; 13: 601-12.BrodersenJThorsenHKreinerS.Consequences of screening in lung cancer: development and dimensionality of a questionnaireValue Health2010136011210.1111/j.1524-4733.2010.00697.xSearch in Google Scholar

6Brodersen J, Siersma VD. Long-term psychosocial consequences of false-positive screening mammography. Ann Fam Med 2013; 11: 106- 15.BrodersenJSiersmaVD.Long-term psychosocial consequences of false-positive screening mammographyAnn Fam Med2013111061510.1370/afm.1466Search in Google Scholar

7Carter JL, Coletti RJ, Harris RP. Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods. BMJ 2015;3 50: g7773.CarterJLColettiRJHarrisRP.Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methodsBMJ2015350g777310.1136/bmj.g7773Search in Google Scholar

8Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009; 360: 1320-8.SchröderFHHugossonJRoobolMJTammelaTLCiattoSNelenVet al.Screening and prostate-cancer mortality in a randomized European studyN Engl J Med20093601320810.1056/NEJMoa0810084Search in Google Scholar

9Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V et al. Prostate-cancer mortality at 11 years of follow-up. N Engl J Med 2012; 366: 981-90.SchröderFHHugossonJRoobolMJTammelaTLCiattoSNelenVet al.Prostate-cancer mortality at 11 years of follow-upN Engl J Med20123669819010.1056/NEJMoa1113135Search in Google Scholar

10Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Zappa M, Nelen V et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet 2014; 384: 2027-35.SchröderFHHugossonJRoobolMJTammelaTLZappaMNelenVet al.Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-upLancet201438420273510.1016/S0140-6736(14)60525-0Search in Google Scholar

11Harris RP, Sheridan SL, Lewis CL, Barclay C, Vu MB, Kistler CE et al. The harms of screening: a proposed taxonomy and application to lung cancer screening. JAMA Intern Med 2014; 174: 281-5.HarrisRPSheridanSLLewisCLBarclayCVuMBKistlerCEet al.The harms of screening: a proposed taxonomy and application to lung cancer screeningJAMA Intern Med2014174281510.1001/jamainternmed.2013.1274524322781Search in Google Scholar

12Jessen LKH, Harris R, Brodersen J. Consequences of overdiagnosis. Preventing Overdiagnosis 2016. 3rd International Conference, Washington DC, 2015.JessenLKHHarrisRBrodersenJ.Consequences of overdiagnosisPreventing Overdiagnosis 20163rd International ConferenceWashington DC2015Search in Google Scholar

13Heleno B, Thomsen MF, Rodrigues DS, J⊘rgensen KJ, Brodersen J. Quantification of harms in cancer screening trials: literature review. BMJ 2013; 347: f5334.HelenoBThomsenMFRodriguesDSJ⊘rgensenKJBrodersenJ.Quantification of harms in cancer screening trials: literature reviewBMJ2013347f533410.1136/bmj.f5334479339924041703Search in Google Scholar

14Preveting overdiagnosis. Available Mar 2017, from: http://www.preventingoverdiagnosis.net/.Preveting overdiagnosis. Available Mar 2017, fromhttp://www.preventingoverdiagnosis.net/Search in Google Scholar